CYH: Community Health Systems, Inc. EV/EBITDA Multiple
Healthcare operator Community Health Systems (CYH) is facing a liquidity shortage, as massive loans and physician payroll expenses erode profits. The price trajectory of the asset based on the EV/EBITDA metric, which currently stands at 8.50, helps track the situation. The business relies on steady demand across regional hospitals and is reducing debt to boost FCF, although government insurance and staffing shortages are weighing on margins.
Summary analytical data breakdowns for chs.net (CYH)
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- debt level and financial liquidity data:
Debt to Equity Community Health Systems|CYH - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Community Health Systems, Inc.|CYH - Company Aggregate Debts|Debt to Book Capitalization Ratio Community Health Corp|CYH - Company Long-Term Indebtedness|Company Short-Term Debts Community Health Systems|Quick Liquidity Indicator chs.net
- business earnings and investment ratios data:
CYH - Profit After Payment of Taxes|Future Profit Community Health Systems|CYH - Market Cap to Earnings|Projected Price to Earnings Community Health Systems|CYH - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Community Health Corp|CYH - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Community Health Systems|CYH - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth chs.net|CYH - Earnings growth in current year|Net earnings per share growth forecast for next year Community Health Systems
Fundamental company analysis:CYH (Community Health Systems Inc)
Fundamental valuation of capital-intensive enterprises requires considering the total enterprise value relative to earnings before interest, taxes, depreciation, and amortization. This indicator measures the real value of assets accounting for the debt load, which the EV/EBITDA ratio for heavy business currently prices in via real-time assessment. An increase in this metric signals either a revaluation or an increase in debt. For Community Health Systems (CYH), this is critical, as the outsourcing of non-core services and IT infrastructure directly impacts operational efficiency and the final multiple.
Competitor analysis for Community Health Systems
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|Fresenius Medical Care - EV/EBITDA Multiple|solventum.com (SOLV) - Enterprise Value to EBITDA Ratio|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Universal Health Services, Inc. (UHS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|Enterprise Value to EBITDA Ratio RadNet Management (RDNT)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Option Care Health (OPCH)|Enterprise Value to EBITDA Ratio surgerypartners.com SGRY|Premier - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple National Vision Holdings, Inc. EYE|PGNY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ARDT (Ardent Health Corp) - Enterprise Value to Operating Income Before Depreciation|SEM: EV/EBITDA Multiple|ASTH - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MD|USPH (US Physical Therapy Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio PNTG (Pennant Group Inc)|ORGO - Company Value to EBITDA|Nutex Health Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation AUNA|SBC Medical Group - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation EOLS (Evolus Inc)|SKIN: EV/EBITDA Multiple|Company Value to EBITDA MediWound (MDWD)|BTMD (biote Corp.) - EV/EBITDA Multiple|EV/EBITDA Multiple thejoint.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PIII (p3hp.org)|Gain Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio EUDA (euda.com)|Basel Medical Group Limited - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CLGN (CollPlant Biotechnologies)|CUPR (Cuprina Holdings) - Enterprise Value to EBITDA Ratio|Concord Medical Services Holdings - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization American Shared Hospital Services, Inc.|MEDIROM Corp (MRM) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ALBT (Avalon GloboCare)|DHAI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carmell Therapeutics XAGE|Total Company Value to Operating Income Before Depreciation Ratio NewGenIvf Group (NIVF)|ATIP: Enterprise Value to EBITDA Ratio|CareMax, Inc - Enterprise Value to Operating Income Before Depreciation Ratio|KDLY: EV/EBITDA Multiple|Company Value to EBITDA modivcare.com (MODV)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Novo Integrated Sciences, Inc.|Enterprise Value to EBITDA Ratio SunLink Health Systems, Inc (SSY)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
